EP Patent

EP2148670A1 — Titration of tapentadol

Assigned to Gruenenthal GmbH · Expires 2010-02-03 · 16y expired

What this patent protects

The invention relates to the use of tapentadol for the manufacture of a medicament comprising at least one administration unitAcontaining doseaof tapentadol and at least one administration unitBcontaining dosebof tapentadol, where dosea< doseb, for the treatment of pain.

USPTO Abstract

The invention relates to the use of tapentadol for the manufacture of a medicament comprising at least one administration unitAcontaining doseaof tapentadol and at least one administration unitBcontaining dosebof tapentadol, where dosea< doseb, for the treatment of pain.

Drugs covered by this patent

tapentadol-hydrochloride (TAPENTADOL HYDROCHLORIDE)

Patent Metadata

Patent number: EP2148670A1
Jurisdiction: EP
Classification: —
Expires: 2010-02-03
Drug substance claim: No
Drug product claim: No
Assignee: Gruenenthal GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.